Paper ยท 31292550
Tumour lineage shapes BRCA-mediated phenotypes.
Jonsson P and 30 others. Nature, 2019. Cited by 347 papers, by iCite.
11 sourcespapers-2026-11-12-0.1.0
Cite this record
ConductScience Library. Tumour lineage shapes BRCA-mediated phenotypes. Papers, record 31292550. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/31292550
On this page
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Publication types
- Journal Article, Research Support, N.I.H., Extramural, Research Support, Non-U.S. Gov't
- PubMed
Topics12
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Cell Lineage | Major topic |
| Genes, BRCA1 | Major topic |
| Genes, BRCA2 | Major topic |
| Mutation | Major topic |
| Neoplasms | Major topic |
| Phenotype | Major topic |
| Alleles | |
| Cohort Studies | |
| Heterozygote | |
| Humans | |
| Poly(ADP-ribose) Polymerase Inhibitors | |
| Zygote |
Source PubMed
Grants8
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by | Source |
|---|---|---|---|---|---|
| R01 CA207244 | NCI NIH HHS | United States | R01CA207244 | PubMed and NIH | NIH RePORTER |
| R01 CA227534 | NCI NIH HHS | United States | R01CA227534 | PubMed and NIH | NIH RePORTER |
| P50 CA092629 | NCI NIH HHS | United States | P50CA092629 | PubMed and NIH | NIH RePORTER |
| R25 CA233208 | NCI NIH HHS | United States | R25CA233208 | PubMed | NIH RePORTER |
| P30 CA008748 | NCI NIH HHS | United States | P30CA008748 | PubMed and NIH | NIH RePORTER |
| P50 CA221745 | NCI NIH HHS | United States | P50CA221745 | PubMed | NIH RePORTER |
| R01 CA204749 | NCI NIH HHS | United States | R01CA204749 | PubMed and NIH | NIH RePORTER |
| U54OD020355 | NIH | NIH RePORTER |
Trials0
The trials whose ClinicalTrials.gov record lists the paper, and the trial numbers the paper's PubMed record names.
None in this release.
Comments and corrections5
PubMed's comments and corrections, NLM's own indexing: retractions first, then expressions of concern, errata and updates, and comments last.
| Kind | PMID | Title | In Papers | Source |
|---|---|---|---|---|
| Erratum in | 31,822,847 | Author Correction: Tumour lineage shapes BRCA-mediated phenotypes. | https://conductscience.org/library/papers/31822847 | PubMed |
| Comment in | 31,582,817 | Why BRCA mutations are not tumour-agnostic biomarkers for PARP inhibitor therapy. | https://conductscience.org/library/papers/31582817 | PubMed |
| Comment in | 31,610,093 | Melanoma predisposition-A limited role for germline BRCA1 and BRCA2 variants. | https://conductscience.org/library/papers/31610093 | PubMed |
| Comment in | 32,668,122 | Etiologic Index - A Case-Only Measure of BRCA1/2-Associated Cancer Risk. | https://conductscience.org/library/papers/32668122 | PubMed |
| Comment in | 33,772,500 | Heterozygous PALB2 Mutation in a Boy with Acute Lymphoblastic Leukemia and Subsequent Metastatic Ewing Sarcoma. | https://conductscience.org/library/papers/33772500 | PubMed |
References44
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 8,524,414 | Identification of the breast cancer susceptibility gene BRCA2. | Nature | 1995 | https://conductscience.org/library/papers/8524414 | PubMed |
| 2 | 7,545,954 | A strong candidate for the breast and ovarian cancer susceptibility gene BRCA1. | Science | 1994 | https://conductscience.org/library/papers/7545954 | PubMed |
| 3 | 22,193,408 | BRCA1 and BRCA2: different roles in a common pathway of genome protection. | Nat Rev Cancer | 2011 | https://conductscience.org/library/papers/22193408 | PubMed |
| 4 | 27,664,246 | Prevention and screening in BRCA mutation carriers and other breast/ovarian hereditary cancer syndromes: ESMO Clinical Practice Guidelines for cancer prevention and screening. | Ann Oncol | 2016 | https://conductscience.org/library/papers/27664246 | PubMed |
| 5 | 28,831,036 | BRCA locus-specific loss of heterozygosity in germline BRCA1 and BRCA2 carriers. | Nat Commun | 2017 | https://conductscience.org/library/papers/28831036 | PubMed |
| 6 | 26,775,620 | BRCAness revisited. | Nat Rev Cancer | 2016 | https://conductscience.org/library/papers/26775620 | PubMed |
| 7 | 10,837,032 | Gross chromosomal rearrangements and genetic exchange between nonhomologous chromosomes following BRCA2 inactivation. | Genes Dev | 2000 | https://conductscience.org/library/papers/10837032 | PubMed |
| 8 | 11,239,455 | BRCA2 is required for homology-directed repair of chromosomal breaks. | Mol Cell | 2001 | https://conductscience.org/library/papers/11239455 | PubMed |
| 9 | 10,549,283 | Brca1 controls homology-directed DNA repair. | Mol Cell | 1999 | https://conductscience.org/library/papers/10549283 | PubMed |
| 10 | 23,945,592 | Signatures of mutational processes in human cancer. | Nature | 2013 | https://conductscience.org/library/papers/23945592 | PubMed |
1 to 10 of 44
See all 44 referencesCited by258
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 347 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42,598,072 | Interpreting homologous recombination deficiency in rare gynecological cancers: A case of primary mucinous endometrial adenocarcinoma of gastrointestinal type. | Gynecol Oncol Rep | 2026 | https://conductscience.org/library/papers/42598072 | PubMed |
| 42,521,810 | Bridging the gap: integrating hereditary cancer into precision oncology. | Eur J Hum Genet | 2026 | https://conductscience.org/library/papers/42521810 | PubMed |
| 42,498,744 | Chinese expert consensus on precision testing and molecular diagnosis of pancreatic cancer (2025). | Br J Cancer | 2026 | https://conductscience.org/library/papers/42498744 | PubMed |
| 42,308,463 | Phase II Study of Adavosertib in Patients With Tumors Containing BRCA1 and BRCA2 Mutations: Results From the NCI-MATCH ECOG-ACRIN Cancer Research Group (EAY131) Subprotocol Z1I. | JCO Precis Oncol | 2026 | https://conductscience.org/library/papers/42308463 | PubMed |
| 42,186,016 | Whole genome sequencing in oesophageal adenocarcinoma unmasks potential precision therapies. | BMC Cancer | 2026 | https://conductscience.org/library/papers/42186016 | PubMed |
| 42,132,987 | Why are Some Tissues More Vulnerable? Revisiting Tissue Specificity in Hereditary Cancer Syndromes. | Mol Diagn Ther | 2026 | https://conductscience.org/library/papers/42132987 | PubMed |
| 41,998,785 | Estrogen receptor-positive, BRCA1-deficient breast cancer: BRCA1-epimutated tumors presenting a piece to the puzzle. | Breast Cancer Res | 2026 | https://conductscience.org/library/papers/41998785 | PubMed |
| 41,990,295 | Germline Pathogenic Variants in Homologous Recombination Pathway Genes Are Frequent in Pancreatobiliary Ampullary Carcinoma. | JCO Precis Oncol | 2026 | https://conductscience.org/library/papers/41990295 | PubMed |
| 41,895,280 | Cancer type-specific variation in patterns of driver alterations across 50,000 tumors. | Cancer Cell | 2026 | https://conductscience.org/library/papers/41895280 | PubMed |
| 41,867,230 | Cancer genomic profiling predicts pathogenicity of BRCA1 and BRCA2 variants. | medRxiv | 2026 | https://conductscience.org/library/papers/41867230 | PubMed |
1 to 10 of 258
See all 258 cited byGenes28
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes | Source |
|---|---|---|---|---|
| ATM | 472 | PubTator's text mining | https://conductscience.org/library/genes/472 | NCBI Gene |
| BARD1 | 580 | PubTator's text mining | https://conductscience.org/library/genes/580 | NCBI Gene |
| BRCA1 | 672 | PubTator's text mining | https://conductscience.org/library/genes/672 | NCBI Gene |
| BRCA2 | 675 | PubTator's text mining | https://conductscience.org/library/genes/675 | NCBI Gene |
| BRIP1 | 83,990 | PubTator's text mining | https://conductscience.org/library/genes/83990 | NCBI Gene |
| CD274 | 29,126 | PubTator's text mining | https://conductscience.org/library/genes/29126 | NCBI Gene |
| CHEK1 | 1,111 | PubTator's text mining | https://conductscience.org/library/genes/1111 | NCBI Gene |
| CHEK2 | 11,200 | PubTator's text mining | https://conductscience.org/library/genes/11200 | NCBI Gene |
| CTLA4 | 1,493 | PubTator's text mining | https://conductscience.org/library/genes/1493 | NCBI Gene |
| FANCA | 2,175 | PubTator's text mining | https://conductscience.org/library/genes/2175 | NCBI Gene |
1 to 10 of 28
See all 28 genesDrugs0
The drugs whose trials, in the Pipelines release, list the paper.
None in this release.
Data0
The data bank entries PubMed's record names. Trial numbers are under Trials.
None in this release.
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/31292550
GET https://conductscience.org/api/papers/v1/31292550/authors?page=2